Welcome to our Blog
We'll keep you up to date with our latest news, insights, free resources, and much more.
Don’t worry, we won’t spam you.
Welcome to our Blog
Subscribe to our mailing list.
We'll keep you up to date with our latest news, insights, free resources, and much more.
Don’t worry, we won’t spam you.
May 12, 2022. 5:07 PMPharma
Astra Zeneca. “Lynparza” is a light at the end of the tunnel for triple-negative breast cancer.
The FDA has approved the first drug against the mortal type of breast cancer. Lynparza, unlike its predecessors, treats HER2/neu negative cancer, which has been increasing in the last years, giving hope to patients suffering from this terrible disease.
April 28, 2022. 5:57 AMPharma
Biogen’s big blow on its top seller
Biogen's big seller drug Adulhem has been retired from Medicare and Medicaid after failing to prove a real benefit to the patients suffering from Alzheimer's disease. Is this going to affect the market value of Biogen? What is next in the Alzheimer's medication?
January 28, 2022. 8:00 AMRobotic Surgery
“Intuitive Surgical” first sign of concern?
Intuitive surgical, the giant of robotic surgery has suffered a big blow on its quarterly goals by not reaching its equipment placement expected. Is this a sign of concern for the upcoming future of the massive company?
Subscribe to our mailing list.
We'll keep you up to date with our latest news, insights, free resources, and much more.
Don’t worry, we won’t spam you.